YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Cadila Health
Cadila Health
BSE: 532321NSE: CADILAHCISIN: INE010B01027

20th-Oct-2020 14:44Source: BSE

Cadila Healthcare - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2020

CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2020 ,inter alia, to consider and approve approval of unaudited financial results for the quarter / half year ended on September 30, 2020

Sections